Funded Projects

It has been appreciated for decades that cognitive decline and dementia are frequently accompanied by changes that cause proteins within brain cells to clump abnormally into structures called neurofibrillary tangles. Resilient brains are better able to resist this process but the underlying mechanisms for why individuals’ brains are either more or less resilient are not fully understood.

The medial entorhinal cortex (MEC), the brain’s “inner GPS”, contains an internal map of external space. Rather than representing a static spatial map, however, MEC neurons can spontaneously switch between multiple maps (Low et al., 2021). In this project, we will investigate if spontaneous map switches reflect changes in an animal’s latent internal state.

Constipation and diarrhea, caused by aberrant water absorption in the colon, impose substantial health burdens. The enteric nervous system (ENS) harbors a specialized circuit for water absorption, the secretomotor/vasodilator circuit, but its role in the proximal colon remains poorly understood.

Understanding representational drift—the brain’s evolving representation of its environment—is pivotal to gaining insights into neural computation. Despite its significance, the study of representational drift has been constrained by the scarcity of suitable datasets and methods.

This team aims to understand differences in language processing between bilingual and monolingual speakers and how these differences contribute to neuroplasticity. Their Koret project will use EEG to discover how semantic predictions are formed and whether knowledge of multiple languages influences these predictions.

In this highly interdisciplinary project, PhD candidate Alberto Tono is pursuing the novel application of combined EEG and immersive reality to streamline workflows in building design and construction.

The causes of neurodegenerative disorders like multiple sclerosis or Alzheimer’s disease are incompletely understood, hindering our ability to gain precise diagnoses and design effective therapeutics. Understanding how the circadian rhythms regulate myelin-forming precursors will impart unique insights into normal and aberrant myelination and will have a positive impact on developing therapeutic strategies to restructure myelin.

This team will use their Neuroscience:Translate award to develop the first wearable ultrasound (US) device for the treatment of inflammatory diseases, such as Rheumatoid Arthritis (RA) and Inflammatory Bowel Disease.

People with Parkinson’s Disease (PD) have different types of bacteria in their guts compared to people without neurological diseases. We will study which gut bacteria in people with PD to gain a better understanding of how gut bacteria contribute to inflammation in the body and in the brain of people with this condition. 

With an aging population, neurodegenerative disorders contribute increasingly to our global health burden with no cure or effective treatments. Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two neurodegenerative disorders that are distinct in clinical presentation (ALS impairs movement/breathing, whereas FTD impairs behavior/cognition).

This team will use their Neuroscience:Translate award to develop a large-scale bi-directional neural interface that will restore high-fidelity vision to people blinded by retinal degeneration.

Brain-computer interfaces (BCIs) are systems that enable using neural activity to control and interact with external devices. For people who lose the ability to move or speak due to injury or disease, BCIs provide a potential avenue to restore this loss of function.

Why do all our brains mature and age in different ways, leading to different cognitive and behavioral outcomes? We envision a novel method that “copies” the information from the RNAs made by the neurons to sensor RNAs we artificially introduce into live animals. 

While acute pain is an important biological signal in response to injured tissue, chronic pain occurs when the pain signaling outlasts the initial injury and has deleterious effects on health and quality of life. Chronic pain represents an enormous public health burden with few therapeutic options.

We understand a lot about how the brain gets rewired when learning a new skill by repetitive practice, such as hitting a curveball. However, how learning and experience alter the innate behaviors that we are born with is poorly understood.

There is one characteristic of all neurodegenerative diseases: the accumulation and aggregation of abnormal proteins in the patient’s brain. These aggregations are thought to induce neuronal cell death and brain degeneration.

This team will use their Neuroscience:Translate award to develop an entirely new class of ischemic stroke treatment device that will lead to improved clot extraction to improve the success of endovascular thrombectomy.

We propose to apply mass spectrometry techniques to measure BHB-Phe and other KD metabolites in children undergoing KD for refractory epilepsy at Stanford. Further, in a mouse model of refractory genetic epilepsy, we will compare targeted BHB-Phe treatment to full KD treatment using transcriptomics, EEG assessment of seizures and cognitive testing.

This team will use their Neuroscience:Translate award to employ a novel therapeutic technique to correct pathogenic mutations causing Parkinson’s disease.

Sleep is a critical behavioral state that fulfills essential needs for health, including clearing waste products (e.g., protein aggregates) from the brain. But sleep is not everlasting. As humans age, sleep quality strikingly deteriorates, and this decline is associated with dementias (e.g., Alzheimer’s disease).

Millions of people are blind, yet we still don’t have the technology to satisfactorily restore vision. I aim to create a prosthetic device to do so. This device can be implanted in the eyes of a blind patient, resting on a tissue layer called the retina.

We propose a new line of research whose goal is to examine the druggability of a protein-protein interface involving ApoE, an apolipoprotein whose gene variants represent the strongest genetic risk factor for AD.

With an aging population, neurodegenerative disorders contribute increasingly to our global health burden with no cure or effective treatments. Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two neurodegenerative disorders that are distinct in clinical presentation (ALS impairs movement/breathing, whereas FTD impairs behavior/cognition).

It is more common nowadays for people to have their own wearable devices to measure physiological signals like heart rate and respiration to keep track of physical diseases. However, monitoring decline in cognitive functions or development of neurodegenerative diseases, such as Parkinson’s (PD), is still complex and tricky.